The COMBINE 3 trial demonstrated that once-weekly IcoSema (700U/2 mg/mL) was non-inferior to insulin glargine U100 taken daily in combination with insulin aspart for people with type 2 diabetes ...

COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart ...

In Fiasp, niacinamide (vitamin B 3) has been added to aspart to help increase the speed of the initial insulin absorption. For mealtime use, it is indicated to be dosed at the beginning of a meal ...

Author:Emery Winter Published:4:40 PM EST November 16, 2023 Updated:12:21 PM EST November 17, 2023 ...

Credit: Orawan - stock.adobe.com Author: Emery Winter Published: 3:40 PM CST November 16, 2023 Updated: 11:21 AM CST November 17, 2023 ...

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.

Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in shortage.

Credit: Orawan - stock.adobe.com Author: Emery Winter Published: 4:40 PM EST November 16, 2023 Updated: 12:21 PM EST November 17, 2023 ...

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.